158 filings
Page 3 of 8
4
BIOS Capital Management, LP
7 Sep 22
Lantern Pharma / Aaron G.L. Fletcher ownership change
4:55pm
4
Leslie W. Kreis
7 Sep 22
Lantern Pharma / Leslie W. Kreis ownership change
4:54pm
4
LTRN
Lantern Pharma Inc
9 Aug 22
Lantern Pharma / PANNA SHARMA ownership change
12:00am
10-Q
2022 Q2
LTRN
Lantern Pharma Inc
Quarterly report
8 Aug 22
4:06pm
8-K
LTRN
Lantern Pharma Inc
8 Aug 22
Lantern Pharma Reports Second Quarter 2022 Financial Results and Operational Highlights
4:06pm
3
Maccecchini Maria-Luisa
17 Jun 22
Lantern Pharma / Maria-Luisa Maccecchini ownership change
4:05pm
8-K
LTRN
Lantern Pharma Inc
14 Jun 22
Submission of Matters to a Vote of Security Holders
7:02am
DEFA14A
LTRN
Lantern Pharma Inc
3 May 22
Additional proxy soliciting materials
5:31pm
10-Q
2022 Q1
LTRN
Lantern Pharma Inc
Quarterly report
3 May 22
4:01pm
8-K
LTRN
Lantern Pharma Inc
3 May 22
Lantern Pharma Reports First Quarter 2022 Financial Results and Operational Highlights
4:01pm
DEF 14A
LTRN
Lantern Pharma Inc
Definitive proxy
27 Apr 22
4:45pm
8-K
LTRN
Lantern Pharma Inc
26 Apr 22
Lantern Pharma’s Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern’s Board of Directors
7:15am
8-K
LTRN
Lantern Pharma Inc
25 Apr 22
Other Events
4:05pm
SC 13D/A
Bios Equity Partners, LP
22 Mar 22
Lantern Pharma / Bios Equity Partners ownership change
4:15pm
8-K
LTRN
Lantern Pharma Inc
22 Mar 22
Lantern Pharma Announces Extension of Existing Share Repurchase Program
7:01am
4
BIOS Capital Management, LP
21 Mar 22
Lantern Pharma / Aaron G.L. Fletcher ownership change
6:11pm
10-K
2021 FY
LTRN
Lantern Pharma Inc
Annual report
10 Mar 22
4:06pm
8-K
LTRN
Lantern Pharma Inc
10 Mar 22
Lantern Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Operational Highlights
4:05pm
8-K
LTRN
Lantern Pharma Inc
24 Jan 22
Other Events
7:01am
SC 13G/A
LTRN
Lantern Pharma Inc
11 Jan 22
Lantern Pharma / Empery Asset Management ownership change
10:31am